Gene Symbol | LEP |
Entrez ID | 3952 |
Uniprot ID | P41159 |
Description | leptin |
Chromosomal Location | chr7: 128,241,284-128,257,628 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter |
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IEA |
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
IDA |
BP |
GO:0001542 |
ovulation from ovarian follicle |
The process leading to the rupture of the follicle, releasing the centrally located oocyte into the oviduct. An example of this is found in Mus musculus. |
IEA |
BP |
GO:0001666 |
response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
IEA |
BP |
GO:0001890 |
placenta development |
The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin. |
IDA |
BP |
GO:0001936 |
regulation of endothelial cell proliferation |
Any process that modulates the frequency, rate, or extent of endothelial cell proliferation. |
IDA |
BP |
GO:0002021 |
response to dietary excess |
The physiological process in which dietary excess is sensed by the central nervous system, resulting in a reduction in food intake and increased energy expenditure. |
IEA |
BP |
GO:0003300 |
cardiac muscle hypertrophy |
The enlargement or overgrowth of all or part of the heart muscle due to an increase in size of cardiac muscle cells without cell division. |
IEA |
BP |
GO:0006006 |
glucose metabolic process |
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
IEA |
BP |
GO:0006111 |
regulation of gluconeogenesis |
Any process that modulates the frequency, rate or extent of gluconeogenesis, the formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. |
IEA |
BP |
GO:0006112 |
energy reserve metabolic process |
The chemical reactions and pathways by which a cell derives energy from stored compounds such as fats or glycogen. |
IEA |
BP |
GO:0006114 |
glycerol biosynthetic process |
The chemical reactions and pathways resulting in the formation of glycerol, 1,2,3-propanetriol, a sweet, hygroscopic, viscous liquid, widely distributed in nature as a constituent of many lipids. |
IEA |
BP |
GO:0006629 |
lipid metabolic process |
The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids. |
IBA |
BP |
GO:0006635 |
fatty acid beta-oxidation |
A fatty acid oxidation process that results in the complete oxidation of a long-chain fatty acid. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and occurs by successive cycles of reactions during each of which the fatty acid is shortened by a two-carbon fragment removed as acetyl coenzyme A; the cycle continues until only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively). |
IEA |
BP |
GO:0006909 |
phagocytosis |
An endocytosis process that results in the engulfment of external particulate material by phagocytes. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles. |
IEA |
BP |
GO:0007260 |
tyrosine phosphorylation of STAT protein |
The process of introducing a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein. |
IBA |
BP |
GO:0007565 |
female pregnancy |
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
IEA |
BP |
GO:0007623 |
circadian rhythm |
Any biological process in an organism that recurs with a regularity of approximately 24 hours. |
IEA |
BP |
GO:0008203 |
cholesterol metabolic process |
The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues. |
IEA |
BP |
GO:0008206 |
bile acid metabolic process |
The chemical reactions and pathways involving bile acids, any of a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine. |
IEA |
BP |
GO:0008217 |
regulation of blood pressure |
Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
IEA |
BP |
GO:0008343 |
adult feeding behavior |
Feeding behavior in a fully developed and mature organism. |
ISS |
BP |
GO:0010507 |
negative regulation of autophagy |
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
IDA |
BP |
GO:0010888 |
negative regulation of lipid storage |
Any process that modulates the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. |
IEA |
BP |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
IDA|ISS |
BP |
GO:0014823 |
response to activity |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus. |
IEA |
BP |
GO:0019953 |
sexual reproduction |
A reproduction process that creates a new organism by combining the genetic material of two organisms. It occurs both in eukaryotes and prokaryotes: in multicellular eukaryotic organisms, an individual is created anew; in prokaryotes, the initial cell has additional or transformed genetic material. In a process called genetic recombination, genetic material (DNA) originating from two different individuals (parents) join up so that homologous sequences are aligned with each other, and this is followed by exchange of genetic information. After the new recombinant chromosome is formed, it is passed on to progeny. |
IMP |
BP |
GO:0021954 |
central nervous system neuron development |
The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron. |
IEA |
BP |
GO:0030073 |
insulin secretion |
The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin. |
IEA |
BP |
GO:0030217 |
T cell differentiation |
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex. |
ISS |
BP |
GO:0030300 |
regulation of intestinal cholesterol absorption |
Any process that modulates the frequency, rate or extent of absorption of cholesterol into the blood, and the exclusion of other sterols from absorption. |
IEA |
BP |
GO:0032008 |
positive regulation of TOR signaling |
Any process that activates or increases the frequency, rate or extent of TOR signaling. |
IDA |
BP |
GO:0032099 |
negative regulation of appetite |
Any process that reduces appetite. |
ISS |
BP |
GO:0032310 |
prostaglandin secretion |
The regulated release of a prostaglandin, any of a group of biologically active metabolites which contain a cyclopentane ring, from a cell or a tissue. |
IDA |
BP |
GO:0032355 |
response to estradiol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
IEA |
BP |
GO:0032615 |
interleukin-12 production |
The appearance of interleukin-12 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
IEA |
BP |
GO:0032760 |
positive regulation of tumor necrosis factor production |
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production. |
IEA |
BP |
GO:0032814 |
regulation of natural killer cell activation |
Any process that modulates the frequency, rate or extent of natural killer cell activation. |
IDA |
BP |
GO:0032817 |
regulation of natural killer cell proliferation |
Any process that modulates the frequency, rate or extent of natural killer cell proliferation. |
IDA |
BP |
GO:0032868 |
response to insulin |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
IBA |
BP |
GO:0033197 |
response to vitamin E |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus. |
IEA |
BP |
GO:0033210 |
leptin-mediated signaling pathway |
A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. |
ISS |
BP |
GO:0033686 |
positive regulation of luteinizing hormone secretion |
Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone. |
IEA |
BP |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway |
Any process that activates or increases the frequency, rate or extent of the peroxisome proliferator activated receptor signaling pathway. |
IEA |
BP |
GO:0035630 |
bone mineralization involved in bone maturation |
The deposition of hydroxyapatite, involved in the progression of the skeleton from its formation to its mature state. |
IEA |
BP |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway |
A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, which reduces appetite, the desire or physical craving for food. |
IBA|ISS |
BP |
GO:0042102 |
positive regulation of T cell proliferation |
Any process that activates or increases the rate or extent of T cell proliferation. |
IDA |
BP |
GO:0042269 |
regulation of natural killer cell mediated cytotoxicity |
Any process that modulates the frequency, rate, or extent of natural killer cell mediated cytotoxicity. |
IDA |
BP |
GO:0042445 |
hormone metabolic process |
The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone. |
IEA |
BP |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein |
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat3 protein. |
IEA |
BP |
GO:0042593 |
glucose homeostasis |
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
IEA |
BP |
GO:0042755 |
eating behavior |
The specific behavior of an organism relating to the intake of food, any substance (usually solid) that can be metabolized by an organism to give energy and build tissue. |
IEA |
BP |
GO:0043066 |
negative regulation of apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
IEA |
BP |
GO:0043270 |
positive regulation of ion transport |
Any process that activates or increases the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
BP |
GO:0043410 |
positive regulation of MAPK cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
IDA|ISS |
BP |
GO:0044320 |
cellular response to leptin stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism. |
IDA |
BP |
GO:0045471 |
response to ethanol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
IEA |
BP |
GO:0045639 |
positive regulation of myeloid cell differentiation |
Any process that activates or increases the frequency, rate or extent of myeloid cell differentiation. |
IEA |
BP |
GO:0045765 |
regulation of angiogenesis |
Any process that modulates the frequency, rate or extent of angiogenesis. |
IDA |
BP |
GO:0045906 |
negative regulation of vasoconstriction |
Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction. |
IEA |
BP |
GO:0046325 |
negative regulation of glucose import |
Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
IDA |
BP |
GO:0046427 |
positive regulation of JAK-STAT cascade |
Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity. |
IDA |
BP |
GO:0046628 |
positive regulation of insulin receptor signaling pathway |
Any process that increases the frequency, rate or extent of insulin receptor signaling. |
IEA |
BP |
GO:0046850 |
regulation of bone remodeling |
Any process that modulates the frequency, rate or extent of bone remodeling, the processes of bone formation and resorption that combine to maintain skeletal integrity. |
ISS |
BP |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion |
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone. |
IEA |
BP |
GO:0048639 |
positive regulation of developmental growth |
Any process that activates, maintains or increases the rate of developmental growth. |
IDA |
BP |
GO:0050796 |
regulation of insulin secretion |
Any process that modulates the frequency, rate or extent of the regulated release of insulin. |
IEA |
BP |
GO:0050810 |
regulation of steroid biosynthetic process |
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus. |
IEA |
BP |
GO:0050892 |
intestinal absorption |
Any process in which nutrients are taken up from the contents of the intestine. |
IDA |
BP |
GO:0050901 |
leukocyte tethering or rolling |
Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection). |
IEA |
BP |
GO:0050999 |
regulation of nitric-oxide synthase activity |
Any process that modulates the activity of the enzyme nitric-oxide synthase. |
IDA |
BP |
GO:0051726 |
regulation of cell cycle |
Any process that modulates the rate or extent of progression through the cell cycle. |
IDA |
BP |
GO:0051897 |
positive regulation of protein kinase B signaling |
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
ISS |
BP |
GO:0060587 |
regulation of lipoprotein lipid oxidation |
Any process that modulates the rate, frequency or extent of lipoprotein lipid oxidation. Lipoprotein lipid oxidation is the modification of a lipoprotein by oxidation of the lipid group. |
IEA |
BP |
GO:0060612 |
adipose tissue development |
The process whose specific outcome is the progression of adipose tissue over time, from its formation to the mature structure. Adipose tissue is specialized tissue that is used to store fat. |
IEA |
BP |
GO:0061037 |
negative regulation of cartilage development |
Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. |
IEA |
BP |
GO:0070093 |
negative regulation of glucagon secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of glucagon. |
IEA |
BP |
GO:0071298 |
cellular response to L-ascorbic acid |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus. |
IEA |
BP |
GO:0071300 |
cellular response to retinoic acid |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. |
IEA |
BP |
GO:0072604 |
interleukin-6 secretion |
The regulated release of interleukin-6 from a cell. |
IDA |
BP |
GO:0072606 |
interleukin-8 secretion |
The regulated release of interleukin-8 from a cell. |
IDA |
BP |
GO:0090335 |
regulation of brown fat cell differentiation |
Any process that modulates the rate, frequency, or extent of brown fat cell differentiation. Brown fat cell differentiation is the process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria. |
ISS |
BP |
GO:0098868 |
bone growth |
The increase in size or mass of a bone that contributes to the shaping of that bone. |
ISS |
BP |
GO:1900015 |
regulation of cytokine production involved in inflammatory response |
Any process that modulates the frequency, rate or extent of cytokine production involved in inflammatory response. |
IDA |
BP |
GO:1900745 |
positive regulation of p38MAPK cascade |
Any process that activates or increases the frequency, rate or extent of p38MAPK cascade. |
IDA |
BP |
GO:1904651 |
positive regulation of fat cell apoptotic process |
Any process that activates or increases the frequency, rate or extent of fat cell apoptotic process. |
IEA |
BP |
GO:1990051 |
activation of protein kinase C activity |
Any process that initiates the activity of the inactive enzyme protein kinase C. |
IDA |
BP |
GO:2000366 |
positive regulation of STAT protein import into nucleus |
Any process that activates or increases the frequency, rate or extent of STAT protein import into nucleus. |
IBA |
BP |
GO:2000379 |
positive regulation of reactive oxygen species metabolic process |
Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process. |
IEA |
BP |
GO:2000486 |
negative regulation of glutamine transport |
Any process that stops, prevents or reduces the frequency, rate or extent of glutamine transport. |
IEA |
BP |
GO:2000491 |
positive regulation of hepatic stellate cell activation |
Any process that activates or increases the frequency, rate or extent of hepatic stellate cell activation. |
IEA |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
ISS |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IEA |
MF |
GO:0005179 |
hormone activity |
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
IBA |
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IEA |
MF |
GO:0051428 |
peptide hormone receptor binding |
Interacting selectively and non-covalently with a receptor for peptide hormones. |
IBA |
Domain ID | Description |
---|---|
IPR000065 |
Leptin |
IPR009079 |
Four-helical cytokine-like, core |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
hsa04080 |
Neuroactive ligand-receptor interaction |
KEGG |
hsa04152 |
AMPK signaling pathway |
KEGG |
hsa04630 |
Jak-STAT signaling pathway |
KEGG |
hsa04920 |
Adipocytokine signaling pathway |
KEGG |
hsa04932 |
Non-alcoholic fatty liver disease (NAFLD) |
KEGG |
WP2431 |
Spinal Cord Injury |
WikiPathways |
WP3599 |
Transcription factor regulation in adipogenesis |
WikiPathways |
WP2034 |
Leptin signaling pathway |
WikiPathways |
WP236 |
Adipogenesis |
WikiPathways |
WP3935 |
Leptin Insulin Overlap |
WikiPathways |
WP3934 |
Leptin and adiponectin |
WikiPathways |
WP3594 |
Circadian rythm related genes |
WikiPathways |
WP1403 |
AMP-activated Protein Kinase (AMPK) Signaling |
WikiPathways |
WP2895 |
Differentiation of white and brown adipocyte |
WikiPathways |
h_leptinPathway |
Reversal of Insulin Resistance by Leptin |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0002395 |
Alzheimer'S Disease |
C0004352 |
Autistic Disorder |
C0009375 |
Colonic Neoplasms |
C0010346 |
Crohn Disease |
C0011860 |
Diabetes Mellitus, Non-Insulin-Dependent |
C0015695 |
Fatty Liver |
C0019337 |
Heroin Dependence |
C0020443 |
Hypercholesterolemia |
C0020459 |
Hyperinsulinism |
C0020505 |
Hyperphagia |
C0020538 |
Hypertensive Disease |
C0020619 |
Hypogonadism |
C0021361 |
Female Infertility |
C0021368 |
Inflammation |
C0021655 |
Insulin Resistance |
C0023893 |
Liver Cirrhosis, Experimental |
C0027746 |
Nerve Degeneration |
C0028754 |
Obesity |
C0028756 |
Obesity, Morbid |
C0032617 |
Polyuria |
C0033578 |
Prostatic Neoplasms |
C0033687 |
Proteinuria |
C0036572 |
Seizures |
C0038358 |
Gastric Ulcer |
C0039231 |
Tachycardia |
C0043094 |
Weight Gain |
C0085207 |
Gestational Diabetes |
C0085602 |
Polydipsia |
C0149745 |
Oral Ulcer |
C0241910 |
Hepatitis, Autoimmune |
C0400966 |
Non-Alcoholic Fatty Liver Disease |
C0524620 |
Metabolic Syndrome X |
C0993582 |
Arthritis, Experimental |
C1458155 |
Mammary Neoplasms |
Database Name |
---|
OMIM |
MalaCards |
DisGeNET |
DISEASES |
DGA |
Pubmed ID | Author | Year | Title |
---|---|---|---|
17062763 |
Corton et al. |
2007 |
Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
CRP |
1401 |
P02741 |
0.55 |
A2M |
2 |
P01023 |
0.75 |
STAT3 |
6774 |
P40763 |
0.75 |
HK3 |
3101 |
P52790 |
0.78 |
SIGLEC6 |
946 |
O43699 |
0.52 |
PRKAA2 |
5563 |
P54646 |
0.52 |
GHRL |
51738 |
Q9UBU3 |
0.52 |
UCN |
7349 |
P55089 |
0.55 |
CLU |
1191 |
P10909 |
0.79 |
LEPR |
3953 |
P48357 |
0.82 |